CROs might be the engine that keeps preclinical research moving during COVID-19

Contrary to the situation for in-house preclinical research, preclinical CROs are largely open for business, according to a survey conducted by Science Exchange.

The survey, conducted March 17-20, included CROs and academic laboratories that are verified providers on Science Exchange Inc.’s service marketplace. The exchange, co-founded by CEO Elizabeth Iorns and COO Dan Knox in 2011, connects scientists with research service providers, including CROs, academic labs and government providers...